Acadia Healthcare Company Inc
F:7RA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Acadia Healthcare Company Inc
F:7RA
|
US |
|
C
|
Clientele Ltd
JSE:CLI
|
ZA |
|
S
|
Sequa Petroleum NV
PAR:MLSEQ
|
UK |
|
EFG International AG
F:E2S
|
CH |
|
D
|
Drummond Ventures Corp
XTSX:DVX.P
|
CA |
|
F
|
Fab Form Industries Ltd
XTSX:FBF
|
CA |
|
Lectra SA
F:LET
|
FR |
|
I
|
ISDN Holdings Ltd
XMUN:I8D
|
SG |
|
ESGold Corp
F:Z7D
|
CA |
|
A
|
Asarina Pharma AB (publ)
F:APS
|
SE |
|
E
|
Element 29 Resources Inc
OTC:EMTRF
|
CA |
|
EF EnergyFunders Ventures Inc
XTSX:EFV
|
CA |
|
Founders Metals Inc
XTSX:FDR
|
CA |
Wall St Price Targets
7RA Price Targets Summary
Acadia Healthcare Company Inc
According to Wall Street analysts, the average 1-year price target for 7RA is 23 EUR with a low forecast of 9.89 EUR and a high forecast of 29.07 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 7RA's stock price target?
Price Target
23
EUR
According to Wall Street analysts, the average 1-year price target for 7RA is 23 EUR with a low forecast of 9.89 EUR and a high forecast of 29.07 EUR.
What is the Revenue forecast for Acadia Healthcare Company Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 4 years is 6%.
What is the Operating Income forecast for Acadia Healthcare Company Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is 5%.
